With the launch of the Wegovy pill in the U.S., the drugmaker is adding manufacturing capacity to its Athlone, Ireland site to support current and future GLP-1 treatments.
The deal grants Earendil exclusive rights to WuXi’s payload-linker platform, combining AI-driven antibody discovery with integrated antibody-drug conjugate manufacturing.
The CDMO will present on process analytical technology, digital manufacturing, and real-time analytics as part of FDA’s CBER Advanced Manufacturing Seminar Series.
Tariff refunds are a leadership call for pharmaceutical manufacturers, and executives are weighing whether recovery efforts justify the operational lift.
